The CelonPOWER system provides clinicians with the latest innovative radiofrequency technology for the precise and efficient elimination using bipolar radiofrequnecy ablation of both primary tumours and metastases.
Main benefit of the patented bipolar technology is the restriction of radiofrequency current flow to the volume under treatment (e.g. tumour), as a result of which undesirable side-effects are avoided. In addition to the above, no neutral electrodes are required, which means simplification of the patient’s preparation, cost reduction and increased safety.